Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (100.0%)

Trials by Status

unknown375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
completed

The Constitution and Efficacy of Chinese Medicine of Infertility Male, Female, and Pregnant Female

NCT06393426
unknownphase_2

RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19

NCT05787327
unknownphase_2

Chinese Herbal Medicine for Dialysis-related Myofascial Pain: Study Protocol for A Pilot Randomized Study

NCT04417101
unknown

Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality

NCT03018769

Clinical Trials (4)

Showing 4 of 4 trials
NCT06393426

The Constitution and Efficacy of Chinese Medicine of Infertility Male, Female, and Pregnant Female

Completed
NCT05787327Phase 2

RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19

Unknown
NCT04417101Phase 2

Chinese Herbal Medicine for Dialysis-related Myofascial Pain: Study Protocol for A Pilot Randomized Study

Unknown
NCT03018769

Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4